Galderma Group AG (PY30)
FSX
39.40
+0.80 (+2.07%)
Closed
Oct 23, 2026
Day's Range
38.8039.40
52 wk Range
28.0041.60
Financial Statements - PY30 - Galderma Group AG
Revenue
5.24B▲ 18.0%
Net Income
613.00M▲ 165.4%Net Margin 11.7%
EBITDA
1.18B▲ 21.3%
Free Cash Flow
1.03B▲ 384.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales | 5.24B | 4.44B | 4.11B | 3.25B |
| Cost of Goods | 1.63B | 1.35B | 1.23B | 1.01B |
| Gross Profit | 3.60B | 3.08B | 2.88B | 2.24B |
 Operating Expense | - | - | - | - |
| Operating Income | 876M | 678M | 611M | 346.07M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 638M | 310M | 11M | -44.23M |
| Income Tax | 26M | 79M | 68M | 38.35M |
| Net Income | 613M | 231M | -57M | -83.96M |
| EPS Basic | 0.52 | 0.194 | -0.047987 | -0.082924 |
| EPS Diluted | 0.516 | 0.194 | -0.047987 | -0.082924 |
| Basic Shares Outstanding | 1.17B | 1.18B | 1.18B | 1.01B |
| Diluted Shares Outstanding | 1.17B | 1.18B | 1.18B | 1.01B |
| Ebit | 813M | 666M | 575M | 295.35M |
| Ebitda | 1.18B | 979M | 893M | 593.52M |
| Net Income Continuous Operations | 613M | 231M | -57M | -83.96M |
| Minority Interests | - | - | 0 | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
